SAT vs Escitalopram for Rectal Hypersensitivity

PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2019

Conditions
Rectal HypersensitivityIrritable Bowel Syndrome-Constipation
Interventions
PROCEDURE

Sensory Adaptation Training

This study will last for approximately 3 months and will include 4-6 clinic visits with each visit lasting 2 hours every week or every 2 weeks. At the beginning of each visit we will ask you about your health status and level of satisfaction of your bowel habits. We will then place the pencil-thick probe and balloon inside your rectum and attach it to the barostat device and a computer. We will increase and decrease the volumes of the balloon until the most pressure you can tolerate or a certain level of pressure as measured by the machine is reached, whichever occurs first. You will continue to keep stool diaries and pain diaries for 7 days before and after each visit.

DRUG

Escitalopram Therapy

Escitalopram; 10 mg every day, orally.

Trial Locations (2)

30912

Augusta University, Augusta

52242

University of Iowa Hospitals and Clinics, Iowa City

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Augusta University

OTHER

NCT00584571 - SAT vs Escitalopram for Rectal Hypersensitivity | Biotech Hunter | Biotech Hunter